PortfoliosLab logoPortfoliosLab logo

FBTAX's Sharpe Ratio of 2.49 indicates that for each unit of volatility, it generates 2.49 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 3, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets.

FBTAX Sharpe Ratio Rank


FBTAX Sharpe Ratio Rank: 72.973
Above Average

FBTAX ranks above 72.9% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating above-average returns relative to volatility. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Above-average risk-adjusted returns with room for improvement
  • Compare against category peers to gauge relative positioning
  • Monitor for movement toward top tier or decline toward median
  • Consider pairing with top-tier holdings to improve portfolio efficiency

FBTAX Sharpe Ratio Market Positioning

The chart shows FBTAX's Sharpe Ratio relative to all mutual funds on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.


  • Red zone (bottom 25%): 1.42 or lower
  • Yellow zone (middle 50%): 1.42 to 2.51
  • Green zone (top 25%): 2.51 or higher
  • Top 1%: 4.64+
  • Median: 2.09 — half of all investments score higher

How it compares to other similar mutual funds

The table compares Fidelity Advisor Biotechnology Fund Class A's Sharpe Ratio with other mutual funds in the Health & Biotech Equities category across multiple time periods, showing how FBTAX's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 3, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
FBDIXFranklin Biotechnology Discovery Fund3.24
ETIHXEventide Healthcare & Life Sciences Fund2.68
FBIOXFidelity Select Biotechnology Portfolio2.58
FIJYXFidelity Advisor Biotechnology Fund Class Z2.51
FBTIXFidelity Advisor Biotechnology Fund I Class2.50
FBTAXFidelity Advisor Biotechnology Fund Class A2.49
FBTTXFidelity Advisor Biotechnology Fund Class M2.47
FBTCXFidelity Advisor Biotechnology Fund Class C2.43
RYOIXRydex Biotechnology Fund2.34
LYFIXAlphaCentric LifeSci Healthcare Fund2.15

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows FBTAX's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when FBTAX consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does FBTAX fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio